Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2001
03/28/2001EP1087017A2 The cytoplasmic inhibition of gene expression
03/28/2001EP1087014A1 Hog cholera virus vaccine and diagnostic
03/28/2001EP1087013A2 Immunoglobulins devoid of light chains
03/28/2001EP1087012A1 Groups of genes expressed in human dendritic cells
03/28/2001EP1087011A2 Methods for preventing degradation of protein c
03/28/2001EP1086955A1 Peptides against antibodies elicited by DCM
03/28/2001EP1086954A1 Peptides against autoantibodies elicited by DCM
03/28/2001EP1086742A1 Combinatorial strategies for polymer synthesis
03/28/2001EP1086704A1 Eosinophil chemotactic factor
03/28/2001EP1086377A1 A method of identifying ligands to rna polymerase sigma 70 subunit
03/28/2001EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
03/28/2001EP1086246A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
03/28/2001EP1086234A1 New human carboxypeptidase inhibitor
03/28/2001EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof
03/28/2001EP1086231A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
03/28/2001EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
03/28/2001EP1086229A2 Moraxella catarrhalis polynucleotides and polypeptides
03/28/2001EP1086228A1 Recombinant production of toxoplasma sag1 antigen
03/28/2001EP1086227A1 Novel maize orthologues of bacterial reca proteins
03/28/2001EP1086226A1 Cyclin-dependent kinase inhibitors as plant growth regulators
03/28/2001EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin
03/28/2001EP1086224A1 B2 microglobulin fusion proteins and high affinity variants
03/28/2001EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/28/2001EP1086222A2 Cell cycle regulation proteins
03/28/2001EP1086221A2 Truncated apaf-1 and methods of use thereof
03/28/2001EP1086220A2 Dna coding for gdnf, parts of said dna and gdnf variants
03/28/2001EP1086219A2 Proteins regulating gene expression
03/28/2001EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer
03/28/2001EP1086217A2 Novel angiotensin receptor, production and use thereof
03/28/2001EP1086215A2 Preparation and use of superior vaccines
03/28/2001EP1086213A2 Human genes differentially expressed in colon cancer
03/28/2001EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses
03/28/2001EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
03/28/2001EP1086135A2 "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)"
03/28/2001EP1086133A1 A method for the removal/purification of serum albumins and means for use in the method
03/28/2001EP1086132A1 Gene encoding organic anion transporter
03/28/2001EP1086131A1 Cyclic somatostatin analogs
03/28/2001EP1086130A1 Insulin analogue
03/28/2001EP1086129A1 Anti-angiogenic proteins and methods of use thereof
03/28/2001EP1086128A2 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
03/28/2001EP1086127A1 Novel compounds
03/28/2001EP1086126A1 Cell-permeable peptide
03/28/2001EP1086125A1 Respiratory nitrate reductase alpha subunit
03/28/2001EP1086121A1 Non-enzymatic chemical amidation process
03/28/2001EP1086120A1 Method for preparing virus-safe pharmaceutical compositions
03/28/2001EP1086117A1 Cloning and identification of the motilin receptor
03/28/2001EP1085909A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
03/28/2001EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/28/2001EP1085903A1 Egg surface proteins and methods for use for modulating fertility
03/28/2001EP1085899A1 Retinoic acid inducible dna sequences from lung cells
03/28/2001EP1085898A1 Parasite antigens
03/28/2001EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
03/28/2001EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs
03/28/2001EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
03/28/2001EP0779815B1 Surface-modifying copolymers having cell adhesion properties
03/28/2001EP0495096B1 Plant fatty acid synthases
03/28/2001EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
03/28/2001CN1289373A Inhibition of DNA modulation caused by mutated p53
03/28/2001CN1289366A Human TSC403 gene and human INGIL gene
03/28/2001CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus
03/28/2001CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway
03/28/2001CN1288897A Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment
03/28/2001CN1063796C Preparation method for drythropoietin isoforms
03/28/2001CN1063795C Method for production of glucagon
03/28/2001CN1063757C Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof
03/28/2001CN1063756C Double antigen containing hepatitis B virus and hepatitis C virus core antigen simultaneously
03/27/2001US6207883 DNA sequences coding for a protein conferring male sterility
03/27/2001US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch
03/27/2001US6207817 Fish insulin-like growth factor II promoter
03/27/2001US6207816 High affinity oligonucleotide ligands to growth factors
03/27/2001US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them
03/27/2001US6207813 BMP-6 proteins
03/27/2001US6207812 Chondrosarcoma associated genes
03/27/2001US6207811 Nephrin gene and protein
03/27/2001US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies
03/27/2001US6207806 IGF-I purification process
03/27/2001US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging
03/27/2001US6207804 Genetically engineered antibody analogues and fusion proteins thereof
03/27/2001US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis
03/27/2001US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration
03/27/2001US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/27/2001US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences
03/27/2001US6207798 Includes psuedomonas exotoxin-40 domain modified by replacement of at least two cysteines with alanines and a cell growth factor or hormone domain; targeted anticarcinogenic agents
03/27/2001US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma
03/27/2001US6207646 Immunostimulatory nucleic acid molecules
03/27/2001US6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
03/27/2001US6207642 Member of the TNF family useful for treatment and diagnosis of disease
03/27/2001US6207641 Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
03/27/2001US6207640 Treatment of partial growth hormone insensitivity syndrome
03/27/2001US6207639 Contacting a neuron with a cell adhesion modulating peptide that comprises a cyclic peptide in which nonadjacent amino acid residues are covalently linked to form a peptide ring comprising sequence his-ala-val within cyclic peptide ring
03/27/2001US6207457 Targeted nucleotide sequence delivery and integration system
03/27/2001US6207455 Lentiviral vectors
03/27/2001US6207454 Exposing target mammalian cell that expresses stem cell factor receptor to active stem cell factor or analog, then introducing polynucleotide to cell; gene therapy
03/27/2001US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy
03/27/2001US6207452 Antibody of the anti-proliferation domain of human Bcl-2
03/27/2001US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production
03/27/2001US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics
03/27/2001US6207446 Selection of proteins using RNA-protein fusions
03/27/2001US6207442 Plasmid construction by homologous recombination
03/27/2001US6207440 Bacterial strain includes defined nucleotide sequence; fish aquariums; aquaculture